Navigation Links
Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
Date:5/21/2008

Three of Four HUMIRA Patients from CHARM Study in Remission at One Year

Maintained Remission at Two Years

ABBOTT PARK, Ill., May 21 /PRNewswire-FirstCall/ -- Results from an open-label extension study of two Abbott pivotal studies, CHARM and GAIN, demonstrate that adult moderate-to-severe Crohn's patients treated with HUMIRA(R) (adalimumab) achieved long-term clinical remission and clinical response, respectively, according to data presentations today at Digestive Disease Week(R) (DDW) in San Diego. DDW is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Patients from CHARM and GAIN were followed through into a non-placebo controlled, ongoing open-label extension (OLE) trial. Patients from CHARM were followed a total of two years, and patients from the 4-week GAIN study were followed a total of one year.

The CHARM extension data demonstrated that three out of four patients (77 percent) taking HUMIRA, who were in remission at the end of the one-year pivotal study, maintained clinical remission for an additional year. The GAIN data showed that, of patients with a clinical response at four weeks, approximately 65 percent remained in clinical response at one year, and 40 percent were in clinical remission at one year. Response was measured by change in Crohn's Disease Activity Index (CDAI), a weighted composite score of eight clinical factors that evaluate patient wellness, including daily number of liquid or very soft stools, severity of abdominal pain, levels of general well-being and other measures. Clinical remission was measured as a score of less than 150 and clinical response was measured as a decline of at least 70 points from baseline.

Crohn's disease is a serious, chronic, inflammatory bowel disease that affects more than 500,000 Americans. It affects people of all ages but it is primarily a disease
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
2. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
3. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
4. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
5. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
6. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
7. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
8. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
9. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
10. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
11. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... CLEVELAND , July 10, 2014  The U.S. ... a three-year grant to University Hospitals (UH) Case Medical ... a new national model aimed at improving care for ... Oncology Care," the project will test a unique model ... patients with late-stage disease, significant comorbidities, or demonstrated need ...
(Date:7/10/2014)... 10, 2014  RESMED INC. (NYSE: RMD ) ... fiscal year ended June 30, 2014 results on Thursday, July ... A press release with ResMed,s results will be issued after ... a webcast to discuss operating results and future outlook. ... p.m. US Pacific Time and the live webcast of the ...
(Date:7/10/2014)... , July 10, 2014  Valeant Pharmaceuticals International, Inc. ... announced it has completed the sale to Galderma of ... owned or held by Valeant for $1.4 billion in ... S.A, which recently completed its acquisition of Galderma. ... of our products to a company that is firmly ...
Breaking Medicine Technology:University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
... Today, Siemens (NYSE: SI ) announces ... Medical Informatics Officer (CMIO), of the Health Services (HS) Business ... Health Information Exchange (IHIE), Marc recently served as ... role at Siemens, Marc will be responsible for clinical informatics ...
... 21, 2011 From the floor of the HIMSS11 ... MDRX ) today demonstrated native integration between its ... (EHR) and the Allscripts Enterprise and ... (Logo: http://photos.prnewswire.com/prnh/20100901/CG58147LOGO ) ...
Cached Medicine Technology:Siemens Appoints Overhage as New Chief Medical Informatics Officer 2Allscripts Demonstrates Native Integration of Acute and Ambulatory Electronic Health Records at HIMSS 2Allscripts Demonstrates Native Integration of Acute and Ambulatory Electronic Health Records at HIMSS 3Allscripts Demonstrates Native Integration of Acute and Ambulatory Electronic Health Records at HIMSS 4Allscripts Demonstrates Native Integration of Acute and Ambulatory Electronic Health Records at HIMSS 5
(Date:7/11/2014)... 11, 2014 (HealthDay News) -- Children who have ... for complications and potentially even death than those ... study. However, the Johns Hopkins researchers noted ... The researchers analyzed data on nearly 440,000 simple ... underwent over a 22-year period. The surgeries ...
(Date:7/11/2014)... July 11, 2014 The report ... Specialty Nutrients, Animal Feed), Applications (Regular, Therapeutic, Preventive ... Global Trends & Forecasts to 2019 ” defines ... analysis and forecasting of the market value of ... the driving and restraining factors for the global ...
(Date:7/11/2014)... 2014 Global enterprises today are shifting ... day-to-day management activities. Managed services offer these global enterprises ... economic slowdown resulted into rising operational costs to companies. ... considered to be the global market driver for expanding ... global managed services market is estimated to grow from ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 As reported ... and FiercePharma (Weintraub 7/11/14), a significant number of severe ... sugar, abdominal issues and even death from the highly-promoted ... According to the Times report , a regulatory ... 2013 reported by patients was almost 14% of prescriptions, ...
(Date:7/11/2014)... kind has found that organic foods and crops ... counterparts, including more antioxidants and fewer, less frequent ... unprecedented 343 peer-reviewed publications comparing the nutritional quality ... including fruits, vegetables, and grains. The study team ... organic and non-organic foods. , "Science marches ...
Breaking Medicine News(10 mins):Health News:Emergency Surgeries on Weekends Riskier for Kids: Study 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 4Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 5Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 4Health News:Acthar’s Deadly Adverse Events Revealed 2Health News:Acthar’s Deadly Adverse Events Revealed 3Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3
... ... of the world,s premier ultra-runners, will be the first person to attempt to run 50 miles ... of orphans around the world. , ... York, N.Y. (Vocus) -- Internationally-known endurance athlete Lisa Smith Batchen will attempt to become the first ...
... earmarked funds for smoking prevention, CDC finds , THURSDAY, April ... on cigarettes last year, but none are using that new-found ... 2009, 14 states and the District of Columbia raised their ... $1.18 a pack in 2008 to $1.34 a pack in ...
... Hospital Boston and Harvard Medical School will lead the ... the Office of the National Coordinator for Health Information ... Services (HHS) to support research and development of a ... one of four awarded through the Strategic Health IT ...
... philosopher Frank Sinatra, "is an institute you can,t disparage." Especially, ... marriage may help to prevent fatal strokes in men. ... of a marriage and its association with stroke risk,Prof. Uri ... correlation between reported "happiness" in marriage and the likelihood that ...
... , THURSDAY, April 8 (HealthDay News) -- Although politicians ... records as a major advance over the old paper file ... significantly boosted patient life spans or lowered costs. , ... record adoption, and there,s little evidence for how best to ...
... ... create an online profile and build camaraderie with other Dads around the country. Upload photos, ... more , ... 8, 2010 -- http://AskDads.com , the Internet,s only social networking site exclusively for Dads, ...
Cached Medicine News:Health News:Running Shoes and a Wool Habit: Endurance Athlete and a New Jersey Nun are Running 2,500 Miles of Hope Through America 2Health News:Running Shoes and a Wool Habit: Endurance Athlete and a New Jersey Nun are Running 2,500 Miles of Hope Through America 3Health News:State Cigarette Taxes Not Spent on Anti-Smoking Efforts 2Health News:State Cigarette Taxes Not Spent on Anti-Smoking Efforts 3Health News:Boston researchers lead $15 million federal research grant to support advancement of health IT 2Health News:Different strokes for married folks? 2Health News:AskDads.com Launches the First Social Networking Site Exclusively for Dads 2
... painfree therapy stimulates the spincter and ... contractions and relaxation. By use of ... surgical operations (bladder liftings) may be ... can improve unsatisfying results. DETRUSAM intravesical ...
... Stepper Template Set is the HDR solution ... implantation technique. The template set consists of ... be sutured to the patient and is ... ultrasound Grid Face Plates. The Stepper Holder ...
... is designed for use with the ... prostate brachytherapy. Please be sure that ... the graphics on the Reusable Template. ... from lower surface which fits into ...
Table mount stabilizer system...
Medicine Products: